What is the main business of Interdyscyplinarne Centrum Badawcze?

The main business activity of Interdyscyplinarne Centrum Badawcze focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 25, 2013.

Where is the headquarters located?

The headquarters is located at: Szopena 1, 35-055 Rzeszów.

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.

Interdyscyplinarne Centrum Badawczesp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2013-11-25

Share capital

100,000.00 PLN

Registered address

Szopena 1, 35-055 Rzeszów, Poland

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 1 of 5 financial statements was filed late (for 2021, 76 days late).

2023not filed
202206/07/2023
202129/09/2022
202030/09/2021
201901/07/2020
201814/06/2019

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

Research and experimental development on biotechnology (72.11.Z)Primary

Authorized Representatives

Bartosz Barański – Management Board Member

Ewa Grażyna Mazur – Management Board Member

Stanisław Ryszard Mazur – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations of will on behalf of the company. In the case of a management board consisting of two or more persons, the joint action of two members of the management board or one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Bartosz Barańskiage 55	150	$4,051.86	15%
Ewa Grażyna Mazurage 36	610	$16,477.58	61%
Stanisław Ryszard Mazurage 71	240	$6,482.98	24%

Ewa Grażyna Mazur and Stanisław Ryszard Mazur hold a combined 85% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Read-GeneS.A.	$2,163,474.84	read-gene.com
Bactremsp. z o.o.	$181,958.36	bactrem.pl
AI Corelabsp. z o.o.	$128,365.55	aicorelab.com
Biodecsp. z o.o.	$115,508.63	biodec.pl
Pominnosp. z o.o.	$65,991.17	pominno.pl
ArthecS.A.	$10,911.16	arthec.eu
4cell TherapiesS.A.	$9,123.06	4celltherapies.com
Aiventrosp. z o.o.	$0.00	aiventro.com
BioencaS.A.	$0.00	bioenca.pl
Astrofoodssp. z o.o.	–	astrofarms.space

Change history

Date	Event
2020-11-04	PKD change (Removed: 26 codes; Added: 1 code)
2014-02-05	Share capital increase (10,000.00 PLN → 100,000.00 PLN)
2013-11-25	Entered in the register

FAQ

Last updated: 2026-04-28